Document Detail


Transient Neonatal Liver Disease After Maternal Antenatal Intravenous Immunoglobulins in Gestational Alloimmune Liver Disease Associated With Neonatal Hemochromatosis.
MedLine Citation:
PMID:  25079484     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVES:: Neonatal hemochromatosis is a rare gestational disease resulting in severe fetal liver disease with extrahepatic iron overload sparing the reticuloendothelial system. Recurrrence can be prevented with intravenous immunoglobulin (IVIG) infusions during pregnancy supporting an alloimmune etiology. Our study aimed to assess the effect of antenatal treatment with IVIG on the outcome of pregnancies in women with a past history of documented neonatal hemochromatosis likely due to gestational alloimmune disease (GALD), and to analyse IVIG tolerance.
METHODS:: From 2004 to 2012, 8 pregnant women were treated with IVIG at 1 g/kg body weight weekly from 18 weeks' gestation until birth in a prospective multicentre study.
RESULTS:: All 8 neonates born from treated women survived. Five developed mild neonatal liver disease with hepatomegaly (n = 1), hyperechogenic liver (n = 2), abnormal liver function tests (n = 1), raised serum ferritin (n = 3) and alphafetoprotein (n = 5) levels, or mild iron overload on liver magnetic resonance imaging (MRI) (n = 1). Ferritin and alphafetoprotein levels normalised before 14 days and 2 months respectively. A per-mother basis analysis comparing outcomes of treated (n = 8) and untreated (n = 9) gestations showed a significant improvement in survival of neonates with gestational IVIG therapy (survival 8/8 vs 0/9; P < 0.001). Side effects of IVIG occurred in 5 mothers leading to discontinuation of treatment in 1 case. Preterm neonates born before 37 weeks' gestation had a decreased risk of neonatal liver disease (P = 0.04).
CONCLUSIONS:: Antenatal treatment with IVIG in women at risk for GALD recurrence improves the outcome of pregnancies despite mild signs of transient neonatal liver disease.
Authors:
Julien Baruteau; Sophie Heissat; Pierre Broué; Sophie Collardeau-Frachon; Raymonde Bouvier; Monique Fabre; Hannah Debiec; Pierre Ronco; Martine Uzan; Philippe Narcy; Marie-Pierre Cordier; Alain Lachaux; Thierry Lamireau; Christophe Elleau; Jean Philippe Filet; Delphine Mitanchez; Marie-Pierre Dupuy; Jean François Salaün; Sylvie Odent; James Davison; Dominique Debray; Vincent Guigonis
Related Documents :
11467694 - Growth hormone binding protein in normal and aneuploid pregnancy: a paradoxical decreas...
9516014 - Evaluation of first-trimester screening by fetal nuchal translucency and maternal age.
11339194 - First-trimester increased nuchal translucency and fetal hypokinesia associated with zel...
12478634 - Gender impact on first trimester markers in down syndrome screening.
8684764 - Cesarean delivery for intrapartum fetal heart rate abnormalities: incorporating survey ...
89284 - Central-nervous-system defects in children born to mothers exposed to organic solvents ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-7-24
Journal Detail:
Title:  Journal of pediatric gastroenterology and nutrition     Volume:  -     ISSN:  1536-4801     ISO Abbreviation:  J. Pediatr. Gastroenterol. Nutr.     Publication Date:  2014 Jul 
Date Detail:
Created Date:  2014-7-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8211545     Medline TA:  J Pediatr Gastroenterol Nutr     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Integrin Beta-8, But Not Beta-5 or -6, Protein Expression is Increased in Livers of Children With Bi...
Next Document:  Prolonged Colonic Manometry in Children with Defecatory Disorders.